¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"resting cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting
1. ¾ÈÁ¤- 2. Á¤Áö-, ÈÞ½Ä-, ÈÞ¸é-, ÈÞÁö-
resting blood pressure
¾ÈÁ¤Ç÷¾Ð
resting current
Á¤ÁöÀü·ù
resting membrane potential
¾ÈÁ¤¸·ÀüÀ§
resting nucleus
ÈÞÁö±âÇÙ
resting phase
1. È޽ıâ 2. »çÀ̱â
resting pressure
È޽ıâ¾Ð·Â, ¾ÈÁ¤¾Ð·Â
resting splint
¾ÈÁ¤µ¡´ë, ¾ÈÁ¤ºÎ¸ñ
resting spore
ÈÞÁöȦ¾¾, ÈÞÁöÆ÷ÀÚ
resting tremor
¾ÈÁ¤½Ã¶³¸²
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting phase
È޽ıâ
resting pressure
È޽ıâ¾Ð·Â, ¾ÈÁ¤¾Ð·Â
resting
¾ÈÁ¤-, ÈÞ½Ä-
resting tremor
¾ÈÁ¤¶³¸²
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
cell
¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
beta cell
º£Å¸¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting current
Á¤ÁöÀü·ù
resting nucleus
ÈÞÁöÇÙ, Á¤ÁöÇÙ
resting phase
È޽ıâ
resting blood pressure
¾ÈÁ¤Ç÷¾Ð
resting membrane potential
¾ÈÁ¤¸·ÀüÀ§
resting
¾ÈÁ¤
resting splint
¾ÈÁ¤µ¡´ë, ¾ÈÁ¤ºÎ¸ñ
resting spore
ÈÞÁöȦ¾¾, ÈÞÁöÆ÷ÀÚ
resting tremor
¾ÈÁ¤¶³¸²
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
RP=£¾resting potential
Á¤ÁöÀüÀ§.
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
B cell
B ¼¼Æ÷
B cell
B ¼¼Æ÷.
B cell antigen
B ¼¼Æ÷Ç׿ø
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell hybridoma
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
B cell lymphoma
B¼¼Æ÷¸²ÇÁÁ¾
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
resting cell
Á¤Áö¼¼Æ÷(ïÎòá¬øà)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cell, resting
ÈÞÁö±â¼¼Æ÷
resting wandering cell
ÈÞÁö¼º À¯ÁÖ¼¼Æ÷(ýÌòàõ ë´ñ²á¬øà)
resting bite
Á¤Áö±³ÇÕ(Á¤Áö±³ÇÕ).
resting blood pressure
¾ÈÁ¤½ÃÇ÷¾Ð.
resting current
Á¤ÁöÀü·ù(ïÎòï³êü).
resting expiratory level
¾ÈÁ¤È£±â(äÌð¡û¼Ñ¨)·¹º§.
resting length
¾ÈÁ¤½Ã±æÀÌ.
resting membrane potential
Á¤Áö¸·ÀüÀ§(ïÎòدï³êÈ).
resting nucleus
ÈÞÁöÇÙ(ýÌòú·), Á¤ÁöÇÙ(ïÎ òú·).
resting phase
È޽ıâ(ýÌãÓÑ¢).
resting position
¾ÈÁ¤À§(äÌð¡êÈ).
resting potential
resting salivation
¾ÈÁ¤Å¸¾×ºÐºñ(¡ÝÂù²).
resting spore
ÈÞÁöÆ÷ÀÚ(ýÌòøàí), ÈÞÁöȦ¾¾
resting tremor
¾ÈÁ¤½ÃÁøÀü(äÌð¡ãÁòèïµ).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½